Q3 2019 Investor Presentation
Who we are / what we do
•
Listed on NYSE & ASX, -$15B market cap
World-leading connected health company with more than
9 million 100% cloud-connectable devices
-
More than 10 million patients in AirView monitoring ecosystem
Nearly 80 million patient accounts in out-of-hospital care network
Innovative designer and manufacturer of award-winning
devices and cloud-based software solutions
-
Diagnose, treat, and manage sleep apnea, chronic obstructive
pulmonary disease, and other respiratory conditions
Products and solutions designed to improve patient quality of
life, reduce impact of chronic disease, and lower healthcare
costs
Cloud-based software health applications and devices
designed to provide connected care, improving patient
outcomes and efficiencies for healthcare providers
Tools that allow fewer people to manage more patients
Empower patients to track own health outcomes
© 2019 ResMed | Q3 2019 Investor Presentation | 4
85
Fit pekes
Excelsanded
2
ResMed
ResMedView entire presentation